King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Bader Allahyani
Dr. Bader Allahyani is a Consultant Paediatric Haematologist specialising in non-malignant blood disorders, paediatric thrombosis, and paediatric bone marrow transplantation — a dedicated paediatric haematology specialist in Riyadh, Saudi Arabia providing family-centred care for international patients. He is also Director of a Paediatric Haematology & Oncology Fellowship Programme and completed internationally recognised fellowship training in paediatric haematology/oncology and paediatric BMT.
- Consultant Paediatric Haematologist specialising in non-malignant blood disorders
- Director of a Paediatric Haematology & Oncology Fellowship Programme
- Internationally trained: paediatric residency in Sweden, plus Canadian fellowships in paediatric haematology/oncology and paediatric BMT
- Former Pharmacovigilance Specialist with a national regulatory authority
- Published contributor to Saudi paediatric central venous catheter-related VTE research
Qualifications & Credentials
Medical Degrees
- MBBS — Bachelor of Medicine and Bachelor of Surgery
- Paediatric Residency — Skåne University Hospital, Sweden
Fellowships & Special Training
- Fellowship in Paediatric Haematology/Oncology — Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada
- Fellowship in Paediatric Bone Marrow Transplantation — The Hospital for Sick Children (SickKids), Toronto, Canada
- Subspecialty Training in Non-Malignant Blood Disorders
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) — Registered Consultant
- Canadian paediatric haematology/oncology fellowship training
- American Society of Hematology (ASH) — Member
Areas of Expertise
Major Conditions Treated
- Beta-Thalassaemia and Alpha-Thalassaemia
- Sickle Cell Disease (Paediatric)
- Haemophilia A and B
- Von Willebrand Disease
- Immune Thrombocytopenia (ITP)
- Aplastic Anaemia
- Paediatric Venous Thromboembolism (VTE)
- Central Venous Catheter-Related Thrombosis
- Primary Immunodeficiencies (HSCT Candidates)
- Paediatric BMT Complications
Sub-specialties
- Paediatric Non-Malignant Blood Disorders: Comprehensive management of thalassaemia, sickle cell disease, haemophilia, and immune thrombocytopenia — a trusted paediatric haematologist in Riyadh for international families.
- Paediatric Thrombosis & VTE: Paediatric venous thromboembolism, central venous catheter-related thrombosis, and anticoagulation protocols.
- Paediatric Bone Marrow Transplantation: SickKids-trained paediatric BMT for non-malignant indications including haemoglobinopathies, immunodeficiencies, and bone marrow failure.
Advanced Procedures & Treatments
- Chronic Transfusion and Iron Chelation Therapy
- Hydroxyurea and L-Glutamine for Sickle Cell Disease
- Factor Replacement Therapy (Haemophilia)
- Emicizumab (Haemophilia A)
- IVIG and Thrombopoietin Agonists (ITP)
- Paediatric Anticoagulation (LMWH, DOACs)
- Paediatric BMT for Non-Malignant Disorders
- Gene Therapy Coordination for Haemoglobinopathies
Professional Experience
Current Affiliation
- Consultant, Paediatric Haematology/Oncology — King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia (Present)
- Director, Paediatric Haematology & Oncology Fellowship Programme — KFSHRC, Riyadh (Present)
Past Affiliations
- Fellowship in Paediatric Bone Marrow Transplantation — The Hospital for Sick Children (SickKids), Toronto, Canada
- Fellowship in Paediatric Haematology/Oncology — Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada
- Pharmacovigilance Specialist — Saudi Food & Drug Authority (SFDA) (Past)
- Paediatric Residency — Skåne University Hospital, Sweden
Academic & Research Roles
- Director — KFSHRC Paediatric Haematology & Oncology Fellowship Programme
- Clinical Educator — paediatric haematology trainees and residents
Key Achievements
- Director of a recognised paediatric haematology/oncology fellowship training programme
- Published contributor to Saudi paediatric central venous catheter-related VTE survey:3-4)
- International training across Sweden, Canada, and the Middle East
- Prior regulatory experience at Saudi FDA in pharmacovigilance
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Hematology (ASH)
- Canadian Paediatric Haematology/Oncology training network alumni
- Saudi Society of Haematology
- Saudi Paediatric Association
Research & Publications
Published Papers (Selected)
- Allahyani B, et al. Paediatric Central Venous Catheter-Related Venous Thromboembolism in Saudi Arabia. Blood. 2020;136(Suppl 1):3-4.
- Allahyani B, et al. Paediatric Haemoglobinopathies — Clinical Management Contributions.
Ongoing Research & Clinical Interests
- Paediatric venous thromboembolism prevention and treatment
- Paediatric BMT for haemoglobinopathies
- Gene therapy for paediatric sickle cell disease and beta-thalassaemia
- Paediatric haematology training and education
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Paediatric Oncology Consultation | ₹1,000 – ₹2,500 | $12 – $30 |
| Paediatric Chemotherapy (per cycle) | ₹25,000 – ₹1,75,000 | $300 – $2,100 |
| Paediatric Stem Cell Transplant | ₹18,00,000 – ₹35,00,000 | $21,700 – $42,200 |
| Tumour Biopsy & Molecular Profiling | ₹15,000 – ₹75,000 | $180 – $900 |
| Targeted / Immunotherapy (per cycle) | ₹80,000 – ₹3,00,000 | $960 – $3,600 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Bader Allahyani use in Paediatric Haematology / Oncology — Non-Malignant Blood Disorders treatment?
Dr. Bader Allahyani uses advanced paediatric haematology technologies including chronic transfusion and iron chelation therapy for thalassaemia, hydroxyurea and L-glutamine for sickle cell disease, emicizumab for haemophilia A, paediatric anticoagulation protocols (LMWH and direct oral anticoagulants), paediatric bone marrow transplantation for non-malignant disorders, and gene therapy coordination for haemoglobinopathies. Virtual consultations and remote second opinions are also available to international families through Cancer Rounds.
2. What conditions does Dr. Bader Allahyani specialize in treating?
Dr. Bader Allahyani specialises in Paediatric Non-Malignant Blood Disorders, treating beta- and alpha-thalassaemia, paediatric sickle cell disease, haemophilia A and B, von Willebrand disease, immune thrombocytopenia (ITP), aplastic anaemia, paediatric venous thromboembolism, central venous catheter-related thrombosis, primary immunodeficiencies requiring HSCT, and paediatric BMT complications. International families seeking the best paediatric haematologist in India or Saudi Arabia benefit from his Canadian training.
3. How do I book an appointment with Dr. Bader Allahyani?
Appointments with Dr. Bader Allahyani can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Bader Allahyani?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Bader Allahyani, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Bader Allahyani offer second opinions for Paediatric Haematology / Oncology — Non-Malignant Blood Disorders cases?
Yes. Second opinion consultations for Paediatric Haematology cases — including thalassaemia, sickle cell disease, haemophilia, and paediatric thrombosis — can be arranged via Cancer Rounds, connecting international families with Dr. Bader Allahyani.
